TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Intravenous Injection General Anesthesia Drugs market size was valued at US$ 4.56 billion in 2024 and is projected to reach US$ 5.89 billion by 2030, at a CAGR of 4.3% during the forecast period 2024-2030.
United States Intravenous Injection General Anesthesia Drugs market size was valued at US$ 1.56 billion in 2024 and is projected to reach US$ 1.96 billion by 2030, at a CAGR of 3.9% during the forecast period 2024-2030.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Propofol Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Intravenous Injection General Anesthesia Drugs include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals and AstraZeneca, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Intravenous general anesthesia refers to a method in which one or several drugs are injected intravenously and act on the central nervous system through blood circulation to produce general anesthesia. According to different administration methods, intravenous anesthesia can be divided into single administration method, divided administration method and continuous administration method. Due to some limitations of its own, the use of intravenous general anesthesia was once limited. However, since the 1980s, with the continuous improvement of clinical pharmacology research methods, the development of new strong and short-acting intravenous anesthetics and the advent of computerized intravenous automatic drug delivery systems, intravenous anesthesia has been greatly improved. And development, has now become the mainstream general anesthesia solution.
This report aims to provide a comprehensive presentation of the global market for Intravenous Injection General Anesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Injection General Anesthesia Drugs. This report contains market size and forecasts of Intravenous Injection General Anesthesia Drugs in global, including the following market information:
We has surveyed the Intravenous Injection General Anesthesia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous Injection General Anesthesia Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Intravenous Injection General Anesthesia Drugs Market Segment Percentages, by Type, 2023 (%)
Global Intravenous Injection General Anesthesia Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Intravenous Injection General Anesthesia Drugs Market Segment Percentages, by Application, 2023 (%)
Global Intravenous Injection General Anesthesia Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Intravenous Injection General Anesthesia Drugs Market Segment Percentages, By Region and Country, 2023 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intravenous Injection General Anesthesia Drugs, market overview.
Chapter 2: Global Intravenous Injection General Anesthesia Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Intravenous Injection General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intravenous Injection General Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Intravenous Injection General Anesthesia Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
